Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Brainomix logo — AI-Enabled Precision Medicine

Brainomix

AI-Enabled Precision Medicine

Founded 2010 United Kingdom Oxford, United Kingdom 71 employees Series C Total: $42.85M AI, Biotechnology +2

General Information

Company Name Brainomix
Founded Year 2010
Location United Kingdom Oxford, United Kingdom
Employees 71
Industries AI, Biotechnology, Medical Devices +1
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Brainomix. To contact Brainomix, visit brainomix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Brainomix compare?

A PDF of Brainomix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Brainomix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Brainomix

Brainomix is a UK-based biotechnology startup that focuses on AI Enabled Precision Medicine. Since its establishment as a spin-out from the University of Oxford in 2010, the company has been committed to creating AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.

Their innovative AI-powered imaging biomarkers and software solutions have gained recognition through numerous awards, assisting physicians worldwide in making better, life-saving decisions. Their dedication to advancing the field of precision medicine has garnered the attention of investors, with the latest £400.00K grant investment from Innovate UK in 09 October 2023.

Brainomix's focus on leveraging AI to revolutionize medical treatment decisions presents an exciting opportunity for potential investors looking to support groundbreaking advancements in biotechnology and healthcare.

Business keywords: AI-powered imaging biomarkers, Precision medicine, Medical imaging technology, Diagnostic software, Machine learning in healthcare, Treatment decision support, University spin-out, Healthcare innovation, Artificial intelligence in medicine

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series C €16.70M 5
Parkwalk Advisors Hostplus
Parkwalk Advisors, Hostplus +3
20 Mar 2025
Grant £400.00K 1
Innovate UK
Innovate UK
09 Oct 2023
Series B £16.00M 4
Parkwalk Advisors Innovations EIS Fund
Parkwalk Advisors, Innovations EIS Fund +2
16 Dec 2021
Venture Round £7.00M 4
Parkwalk Advisors Innovations EIS Fund Chimera Partners Limited
Parkwalk Advisors, Innovations EIS Fund +2
03 Apr 2018
Series B £1.50M 2
Parkwalk Advisors Chimera Partners Limited
Parkwalk Advisors, Chimera Partners Limited
17 Oct 2016
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Oct 2014
Series A £1.20M 2
Parkwalk Advisors Chimera Partners Limited
Parkwalk Advisors, Chimera Partners Limited
24 Sep 2014
Venture Round Undisclosed 1
Innovations EIS Fund
Innovations EIS Fund
01 Sep 2012

Latest News

View All
Brainomix secures €16.7 milllion to advance its AI imaging technology in healthcare — Eu-startups
Brainomix secures €16.7 milllion to advance its AI imaging technology in healthcare
Eu-startups Mar 20, 2025
AI could save lives in the NHS – but a lack of adoption pathways are holding it back — Sifted
AI could save lives in the NHS – but a lack of adoption pathways are holding it back
Sifted Apr 24, 2024

Brainomix Alternatives & Competitors

View All Alternatives
Brainomix vs
Nucleai
Nucleai United States

The leading Spatial Biology Software Platform for Precision Medicine.

Venture round
105 employees
AI, Health Care
Compare Brainomix vs Nucleai
Brainomix vs
Elucid
Elucid United States

Bringing Imaging to Life

Series C
99 employees
Analytics, Biotechnology
Compare Brainomix vs Elucid
Brainomix vs
LPIXEL Inc.
LPIXEL Inc. Japan

NEW VALUES FROM LIFE'S DISCOVERIES

Non Equity Assistance
31 employees
Biotechnology, Care Economy
View all alternatives

FAQ About Brainomix

AI-Enabled Precision Medicine
Brainomix was founded in 2010.
Brainomix is headquartered in Oxford, United Kingdom.
Brainomix operates in AI, Biotechnology, Medical Devices and Machine Learning. Its work centres on AI-powered imaging biomarkers, Precision medicine, Medical imaging technology and Diagnostic software.
Brainomix has approximately 71 employees.
Brainomix has completed 8 funding rounds, raising a total of $42.85M. The latest funding stage is Series C.
Top alternatives and competitors to Brainomix include Nucleai, Elucid, LPIXEL Inc., Idoven, MVision AI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Brainomix and Nucleai are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Brainomix, https://bouncewatch.com/company/brainomix, updated 20 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes